Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Virol ; 153(9): 1783-6, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18636220

RESUMO

Complete nucleotide sequences of three strains (I, III, and IV) of Barley yellow mosaic virus (BaYMV) isolated in Japan were determined. The length of the genome was the same among the three strains; RNA1 was 7,642 nt and RNA2 was 3,585 nt. The molecular phylogenetic analysis showed that strain I was most closely related to the Chinese isolate, and these two strains formed one cluster with European isolates. Strains II, III, and IV, and the Korean isolate formed another cluster. Amino acid sequences of each viral gene product were compared among strains. The sequences of the VPg protein showed less identity among almost strains (less than 92%) than the sequences of other proteins (more than 93%). VPg is thought to be involved in interactions with host factors, especially initiation factor 4E (eIF4E) or eIF(iso)4E, and infection. Therefore, the relationship between amino acid substitutions and infection of host plants is analyzed.


Assuntos
Filogenia , Potyviridae/classificação , Potyviridae/genética , Hordeum/virologia , Dados de Sequência Molecular , Doenças das Plantas/virologia , Potyviridae/isolamento & purificação , Proteínas Virais/genética
2.
Bone Marrow Transplant ; 42(3): 197-9, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18500372

RESUMO

This study aimed to retrospectively evaluate the incidence of kerato-conjunctivitis in patients receiving TBI followed by high-dose cytarabine, and to clarify how effectively topical corticosteroid eye drops prevent kerato-conjunctivitis in these patients. Fifty-three patients who received cytarabine at a dose of 3 g/m2 every 12 h for 4 days after receiving TBI (12 Gy) as a conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) were evaluated. For the prophylaxis of kerato-conjunctivitis, all patients received betamethasone sodium phosphate eye drops every 6 h, starting 1 day before the first dose of cytarabine and continuing until 1 day after the last dose of cytarabine or the complete resolution of ocular symptoms. For grading of kerato-conjuncitivitis, the National Cancer Institute-Common Toxicity Criteria were used. Among the 53 patients, the grades of kerato-conjunctivitis were grade 0 in 13 patients, grade 1 in 6 patients (11.3%), grade 2 in 10 patients (18.9%) and grade 3 in 25 patients (47.2%). These results strongly suggest that topical corticosteroid eye drops could not effectively prevent the development of cytarabine-induced kerato-conjunctivitis in HSCT recipients who receive high-dose cytarabine following TBI. Further investigation into a more effective prophylaxis for cytarabine-induced kerato-conjunctivitis in this setting is required.


Assuntos
Corticosteroides/uso terapêutico , Citarabina/efeitos adversos , Transplante de Células-Tronco Hematopoéticas/métodos , Ceratoconjuntivite/induzido quimicamente , Adolescente , Adulto , Feminino , Humanos , Ceratoconjuntivite/etiologia , Leucemia/complicações , Masculino , Pessoa de Meia-Idade , Síndromes Mielodisplásicas/complicações , Condicionamento Pré-Transplante/efeitos adversos , Condicionamento Pré-Transplante/métodos , Transplante Homólogo , Irradiação Corporal Total
3.
Chem Pharm Bull (Tokyo) ; 47(9): 1348-50, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10517017

RESUMO

Several thiazolidinedione derivatives (3-7) were designed and synthesized as candidate thyromimetic drugs. Among them, the dihydrogenated compounds, such as 5-2-[[4-(3-tert-butyl-4-hydroxyphenyl)oxy-3,5-diiodophenyl] ethyl]-2,4-thiazolidinedione (6b) and its 3-isopropyl analog (7b), exhibited potent thyroid hormone receptor alpha 1 (TR alpha 1) activation activity.


Assuntos
Receptores dos Hormônios Tireóideos/antagonistas & inibidores , Tiazóis/síntese química , Animais , Células COS , Humanos , Luciferases/genética , Luciferases/metabolismo , Proteínas Nucleares/metabolismo , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores do Ácido Retinoico/efeitos dos fármacos , Relação Estrutura-Atividade , Tiazóis/farmacologia , Fatores de Transcrição/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...